Trial intelligence / Profile preview

IV Iron and IM Vitamin B12 in Anemic Hemodialysis Patients

NCT04627181Phase 4Unknown

Sponsor
Christian Medical College, Vellore
Start
Nov 2020
Primary completion
Mar 2021
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of ferric carboxymaltose, hydroxocobalamin in iron deficiency anemia (IDA), vitamin B12 deficiency anemia, sponsored by Christian Medical College, Vellore. Status: unknown.

02

Drugs

ferric carboxymaltosehydroxocobalamin
03

Conditions

iron deficiency anemia (IDA)vitamin B12 deficiency anemia

Beyond the preview

Go deeper on NCT04627181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04627181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call